8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
A guide to medications and therapies that can alter lipoprotein(a) levels, potentially distorting Lp(a) blood test results. Covers PCSK9 inhibitors, niacin, estrogen, statins, and emerging antisense therapies.
Learn the difference between standard lab reference ranges and functional optimal targets for Lp(a), why this genetic marker matters for cardiovascular risk, and what you can do about elevated levels.
A clinical guide to lipoprotein(a), what your Lp(a) level means, and every evidence-based strategy available to lower it, including emerging therapies, lifestyle factors, and FDA-tracked antisense drugs.
Learn what your Lp(a) blood test result means, what counts as a normal range, what elevated Lp(a) signals for cardiovascular risk, and which treatments are on the horizon.
Lp(a) is a genetically influenced lipoprotein that is being studied as an independent contributor to cardiovascular risk. Learn what the test measures, how thresholds are used, and where the evidence is still developing.
Lipoprotein(a) is a genetically determined cardiovascular risk factor. Learn what normal Lp(a) levels are, what high Lp(a) means for your prescriptions, and which emerging therapies may finally lower it.
Learn when clinicians should order lipoprotein(a) testing, what Lp(a) levels mean, normal ranges, and evidence-based strategies for managing elevated Lp(a) cardiovascular risk.
A clinician-informed guide to the lab panels you should pair with lipoprotein(a) testing, including lipid subfractions, inflammatory markers, and metabolic panels that refine genetic cardiovascular risk.